Finance

Lists
300485:SHE
Beijing Science Sun Pharmaceutical CoLtd
CNÂ¥7,93
-1,73%
(-0,14) 1D
15 Okt., 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300485...
Open
CNÂ¥7,93
High
CNÂ¥8,14
Low
CNÂ¥7,88
Mkt. cap
3,98 mjd
Avg. vol.
4,91 m
Volume
4,63 m
Dividend
0,38%
Quarterly dividend
CNÂ¥0,01
Ex-dividend date
27 Mei 2026
52-wk high
CNÂ¥13,80
52-wk low
CNÂ¥7,77
EPS
-CNÂ¥0,37
Shares outstanding
481,67 m
No. of employees
489
Open
CNÂ¥7,93
High
CNÂ¥8,14
Low
CNÂ¥7,88
Mkt. cap
3,98 mjd
Avg. vol.
4,91 m
Volume
4,63 m
Dividend
0,38%
Quarterly dividend
CNÂ¥0,01
Ex-dividend date
27 Mei 2026
52-wk high
CNÂ¥13,80
52-wk low
CNÂ¥7,77
EPS
-CNÂ¥0,37
Shares outstanding
481,67 m
No. of employees
489
News stories
From web sources and news partners
About Beijing Science Sun Pharmaceutical CoLtd
CEO-
Employees489
Founded20 Mei 1999
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
111,83 m
96,09 m
90,44 m
90,29 m
Cost of goods sold
36,99 m
41,28 m
28,84 m
29,27 m
Cost of revenue
36,99 m
41,28 m
28,84 m
29,27 m
Research and development expenses
21,07 m
21,11 m
8,33 m
21,38 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53,16 m
54,89 m
43,44 m
49,52 m
Operating expense
74,27 m
77,76 m
52,07 m
72,65 m
Total operating expenses
111,26 m
119,05 m
80,91 m
101,92 m
Operating income
562,26 k
-22,96 m
9,53 m
-11,64 m
Other non operating income
-72,37 k
30,17 k
-9,21 k
-7,68 k
EBT including unusual items
7,54 m
-46,89 m
4,44 m
-176,06 m
EBT excluding unusual items
13,15 m
-13,68 m
11,47 m
-13,69 m
Income tax expense
4,74 m
-6,13 m
627,08 k
-26,34 m
Effective tax rate
62,91%
13,07%
14,12%
14,96%
Other operating expenses
554,25 k
3,32 m
1,05 m
3,14 m
Net income
4,07 m
-37,29 m
4,66 m
-148,34 m
Net profit margin
3,64%
-38,81%
5,16%
-164,30%
Earnings per share
-
-
-
-
Interest and investment income
12,66 m
9,34 m
2,02 m
-
Interest expense
-
-454,54 k
-67,50 k
-2,29 m
Net interest expenses
12,66 m
8,89 m
1,95 m
-2,29 m
Depreciation and amortization charges
-
-
-
-
EBITDA
12,27 m
-11,23 m
21,25 m
-361,07 k
Gain or loss from assets sale
111,88 k
-111,88 k
-
-
AI content may include mistakes. Learn more
Google-programme